These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 12132003)

  • 1. Highly active antiretroviral therapy and tuberculosis control in Africa: synergies and potential.
    Harries AD; Hargreaves NJ; Chimzizi R; Salaniponi FM
    Bull World Health Organ; 2002; 80(6):464-9. PubMed ID: 12132003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tuberculosis and HIV interaction in sub-Saharan Africa: impact on patients and programmes; implications for policies.
    Maher D; Harries A; Getahun H
    Trop Med Int Health; 2005 Aug; 10(8):734-42. PubMed ID: 16045459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiretroviral therapy in sub-Saharan Africa: adherence lessons from tuberculosis and leprosy.
    Reid SE; Reid CA; Vermund SH
    Int J STD AIDS; 2004 Nov; 15(11):713-6. PubMed ID: 15537453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scaling up antiretroviral therapy in Africa: learning from tuberculosis control programmes--the case of Malawi.
    Libamba E; Makombe S; Harries AD; Chimzizi R; Salaniponi FM; Schouten EJ; Mpazanje R
    Int J Tuberc Lung Dis; 2005 Oct; 9(10):1062-71. PubMed ID: 16229216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TB and HIV: joint problems, joint solutions?
    Elzinga G; Nunn P
    Bull World Health Organ; 2002; 80(6):469-70. PubMed ID: 12132004
    [No Abstract]   [Full Text] [Related]  

  • 6. Will DOTS do it? A reappraisal of tuberculosis control in countries with high rates of HIV infection.
    De Cock KM; Chaisson RE
    Int J Tuberc Lung Dis; 1999 Jun; 3(6):457-65. PubMed ID: 10383056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of HIV in resource-poor countries, with a focus on sub-Saharan Africa.
    Harries AD
    Lepr Rev; 2002 Sep; 73(3):268-75. PubMed ID: 12449893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trials of anti-tuberculosis treatment in areas of high human immunodeficiency virus prevalence in sub-Saharan Africa.
    Harries AD; Hargreaves NJ; Kumwenda J; Kwanjana JH; Salaniponi FM
    Int J Tuberc Lung Dis; 2000 Nov; 4(11):998-1001. PubMed ID: 11092710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiretroviral drugs for tuberculosis control in the era of HIV/AIDS.
    Williams BG; Dye C
    Science; 2003 Sep; 301(5639):1535-7. PubMed ID: 12920302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integration of tuberculosis and HIV services in sub-Saharan Africa: lessons learned.
    Howard AA; El-Sadr WM
    Clin Infect Dis; 2010 May; 50 Suppl 3():S238-44. PubMed ID: 20397954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A clinical and epidemiologic update on the interaction between tuberculosis and human immunodeficiency virus infection in adults.
    Habib AG
    Ann Afr Med; 2009; 8(3):147-55. PubMed ID: 19884690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoprophylaxis for tuberculosis in HIV-infected individuals in sub-Saharan Africa.
    Nuwaha F
    East Afr Med J; 1998 Sep; 75(9):520-7. PubMed ID: 10493054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Community-based treatment of advanced HIV disease: introducing DOT-HAART (directly observed therapy with highly active antiretroviral therapy).
    Farmer P; Léandre F; Mukherjee J; Gupta R; Tarter L; Kim JY
    Bull World Health Organ; 2001; 79(12):1145-51. PubMed ID: 11799447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preventing recurrent tuberculosis in high HIV-prevalent areas in sub-Saharan Africa: what are the options for tuberculosis control programmes?
    Harries AD; Chimzizi RB; Nyirenda TE; van Gorkom J; Salaniponi FM
    Int J Tuberc Lung Dis; 2003 Jul; 7(7):616-22. PubMed ID: 12870681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Providing HIV care for co-infected tuberculosis patients: a perspective from sub-Saharan Africa.
    Harries AD; Zachariah R; Lawn SD
    Int J Tuberc Lung Dis; 2009 Jan; 13(1):6-16. PubMed ID: 19105873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-related tuberculosis: how well are we doing with current control efforts?
    Maher D; Borgdorff M; Boerma T
    Int J Tuberc Lung Dis; 2005 Jan; 9(1):17-24. PubMed ID: 15675545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contemporary treatment of tuberculosis in HIV prevalent countries in sub-Saharan Africa.
    Nuwaha F
    East Afr Med J; 1998 Jun; 75(6):358-63. PubMed ID: 9803621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential impact of enhanced diagnostic techniques for tuberculosis driven by HIV: a mathematical model.
    Dowdy DW; Chaisson RE; Moulton LH; Dorman SE
    AIDS; 2006 Mar; 20(5):751-62. PubMed ID: 16514306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Community-based multi-disease prevention campaigns for controlling human immunodeficiency virus-associated tuberculosis.
    Suthar AB; Klinkenberg E; Ramsay A; Garg N; Bennett R; Towle M; Sitienei J; Smyth C; Daniels C; Baggaley R; Gunneberg C; Williams B; Getahun H; van Gorkom J; Granich RM
    Int J Tuberc Lung Dis; 2012 Apr; 16(4):430-6. PubMed ID: 22640510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.